Joshua Sharfstein, the Obama administration’s nominee for the No. 2 job at the FDA, will become acting chief of the agency on Monday, according to media reports. Here’s a news alert from InsideHealthPolicy.com “Joshua Sharfstein, selected by the White House for the No. 2 job at FDA, will take over Monday as acting commissioner. […]
The benefits of early anti-HIV therapy for patients with an opportunistic infection outweigh the risks, according to new guidelines from the CDC. The guidelines, developed with the NIH and the Infectious Diseases Society of America, say that for most such infections, early antiretroviral therapy will lead to better outcomes. One exception, however, is tuberculosis. […]
Some of the greatest minds on TB gathered this week here in Rio de Janeiro, Brazil, where advocates, researchers, and donors from all over the world attended the Stop TB Partnership. TB is killing nearly 2 million people a year, yet still gets far too little attention, and the purpose of the conference was to […]
HIV
Since the president’s Feb. 5 State of the Union address pledge to end transmissions of HIV in the United States in the next 10 years, and […]
Tuberculosis
Releasing the most recent domestic and global data on tuberculosis incidence in this week’s Morbidity and Mortality Weekly Report, the U.S. Centers for Disease Control and […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
The following is a guest post by Emily Weaver, PhD, of MEASURE Evaluation Health projects and donors in low-resource countries increasingly aim to leverage existing data […]